CREB1促进免疫检查点HLA-E表达导致多发性骨髓瘤免疫逃逸
本研究探讨多发性骨髓瘤(MM)免疫逃逸机制,发现非经典MHC I类分子HLA-E是主要贡献因子。HLA-E表达与t(4;14)和CD56等侵袭性疾病特征相关,并由TME中IFN-γ诱导。CREB1转录因子通过直接结合启动子调控HLA-E,抑制CREB1可降低HLA-E水平并恢复NK细胞对MM细胞系和患者样本的杀伤活性。
要点
- HLA-E表达与MM侵袭性特征如t(4;14)和CD56表达相关。
- CREB1通过直接结合启动子调控HLA-E,抑制CREB1可降低HLA-E水平。
- 抑制CREB1可恢复NK细胞对MM细胞系和患者样本的细胞毒性。
核心结论
- 结果强烈表明,抑制CREB1通过限制HLA-E表达和增强NK细胞活性来促进MM的抗肿瘤免疫。
研究设计与样本
- 本研究为实验室研究,涉及MM细胞系和患者样本,未报告样本量。
主要发现
- HLA-E表达与侵袭性疾病特征如t(4;14)和CD56表达相关,并由TME中IFN-γ诱导。
- CREB1转录因子通过直接结合启动子调控HLA-E,基因组和药理学抑制CREB1可降低HLA-E水平,即使在IFN-γ或IFN-γ激活剂(如免疫调节药物和panobinostat)存在下。
- HLA-E与NKG2A结合,向NK细胞传递抑制信号。
- CREB1抑制剂治疗能够恢复NK细胞介导的对MM细胞系和患者样本的细胞毒性。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) cells effectively escape anti-tumoral immunity to survive in the tumor microenvironment (TME). Herein, we identify non-classical major histocompatibility complex (MHC) class I molecule HLA-E as a major contributing factor in immune escape. Clinically, HLA-E expression correlates with aggressive disease features such as t(4;14) and CD56 expression and is induced by IFN-gamma (IFN-γ) in the TME. We discovered that HLA-E is regulated by cAMP responsive element binding protein 1 (CREB1) transcription factor by direct promoter binding; genomic and pharmacological inhibition of CREB1 reduced HLA-E levels even in the presence of IFN-γ or IFN-γ activating agents, such as immunomodulatory drugs and panobinostat. HLA-E binds to natural killer group 2A (NKG2A), delivering an inhibitor signal to natural killer (NK) cells. Treatment with a CREB1 inhibitor was able to restore NK cell-mediated cytotoxicity against MM cell lines and patient samples. In conclusion, our results strongly demonstrate that CREB1 inhibition promotes anti-tumoral immunity in MM by limiting HLA-E expression and enhancing the activity of NK cells.
引用
- Ismael A, Robinette AJ, Huric L, et al. CREB1 promotes expression of immune checkpoint HLA-E leading to immune escape in multiple myeloma. Leukemia. 2024. PMID: 38902472. doi:10.1038/s41375-024-02303-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。